gaining weight while on tirzepatide Tirzepatide for Medical Weight Loss
Description
This maintenance state requires significantly less pharmaceutical intervention than the active loss phase

This review establishes a compelling link between molecular mechanisms and clinical observations and predicts that long-term use of GLP-1-based therapies may reduce DR risk by improving glycemic control, addressing additional risk factors more effectively than insulin alone, and providing direct retinal neuroprotection through GLP-1 receptor activation

Studies show Wegovy does not reduce the effectiveness of the pill

Or compounded semaglutide

"Blood vessels burst on my face really easily, so I'm so conscious when I'm lifting weights not to let them burst in my face
